Rao Tata Nageswara, Marks-Bluth Jonathan, Sullivan Jessica, Gupta Manoj K, Chandrakanthan Vashe, Fitch Simon R, Ottersbach Katrin, Jang Young C, Piao Xianhua, Kulkarni Rohit N, Serwold Thomas, Pimanda John E, Wagers Amy J
Howard Hughes Medical Institute, USA; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA; Joslin Diabetes Center, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW 2052, Australia; Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
Stem Cell Res. 2015 May;14(3):307-22. doi: 10.1016/j.scr.2015.02.001. Epub 2015 Feb 18.
Blood formation by hematopoietic stem cells (HSCs) is regulated by a still incompletely defined network of general and HSC-specific regulators. In this study, we analyzed the role of G-protein coupled receptor 56 (Gpr56) as a candidate HSC regulator based on its differential expression in quiescent relative to proliferating HSCs and its common targeting by core HSC regulators. Detailed expression analysis revealed that Gpr56 is abundantly expressed by HSPCs during definitive hematopoiesis in the embryo and in the adult bone marrow, but its levels are reduced substantially as HSPCs differentiate. However, despite enriched expression in HSPCs, Gpr56-deficiency did not impair HSPC maintenance or function during steady-state or myeloablative stress-induced hematopoiesis. Gpr56-deficient HSCs also responded normally to physiological and pharmacological mobilization signals, despite the reported role of this GPCR as a regulator of cell adhesion and migration in neuronal cells. Moreover, Gpr56-deficient bone marrow engrafted with equivalent efficiency as wild-type HSCs in primary recipients; however, their reconstituting ability was reduced when subjected to serial transplantation. These data indicate that although GPR56 is abundantly and selectively expressed by primitive HSPCs, its high level expression is largely dispensable for steady-state and regenerative hematopoiesis.
造血干细胞(HSCs)的血液形成受一个仍未完全明确的由一般调节因子和HSC特异性调节因子组成的网络调控。在本研究中,我们基于G蛋白偶联受体56(Gpr56)在静止与增殖的HSCs中的差异表达以及其被核心HSC调节因子共同靶向,分析了它作为候选HSC调节因子的作用。详细的表达分析显示,在胚胎期和成年骨髓中,HSPCs在确定性造血过程中大量表达Gpr56,但随着HSPCs分化,其水平会大幅降低。然而,尽管在HSPCs中表达丰富,但Gpr56缺陷在稳态或清髓性应激诱导的造血过程中并未损害HSPC的维持或功能。尽管有报道称该GPCR在神经元细胞中作为细胞黏附和迁移的调节因子,但Gpr56缺陷的HSCs对生理和药理动员信号的反应也正常。此外,Gpr56缺陷的骨髓在原发性受体中与野生型HSCs以相同效率植入;然而,在进行连续移植时,它们的重建能力降低。这些数据表明,尽管GPR56在原始HSPCs中大量且选择性表达,但其高水平表达在很大程度上对于稳态和再生造血是可有可无的。